Cargando…
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer. The aim of the study was to explore the use of apatinib in treatment of nonsmall cell lun...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902403/ https://www.ncbi.nlm.nih.gov/pubmed/27196461 http://dx.doi.org/10.1097/MD.0000000000003598 |